3 results
Approved WMOCompleted
To determine the efficacy and safety of adding transdermal nitroglycerin to first line chemotherapy for advanced NSCLC.
Approved WMOCompleted
To determine the safety and efficacy of coversin in the treatment of patients with PNH resistant to eculizumab.
Approved WMOCompleted
* The purpose of this study is to to determine the safety profile of long-termCoversin treatment.* To observe the long term safety and efficacy of Coversin over periods in excess of 6 months* To assess the long term patient acceptability of Coversin…